Choo Andre, Ngo Ang Sheu, Ding Vanessa, Oh Steve, Kiang Lim Sai
Stem Cell Group, Bioprocessing Technology Institute, Agency for Science Technology and Research, Singapore 138668.
Methods Cell Biol. 2008;86:15-28. doi: 10.1016/S0091-679X(08)00002-2.
Human embryonic stem cells (hESC) are pluripotent cells that proliferate indefinitely in culture while retaining their ability to differentiate to any cell type in the body. Conventionally, hESC are cultured either directly on feeders or on an extracellular matrix supplemented with conditioned medium (CM) from feeders. To minimize the risk of xenozootic infections, several sources of primary human feeders have been identified. However, this does not eliminate the risk of contaminating hESC with infectious agents from the donor human feeders. In this study, we evaluated the use of the CD105+ /CD24 hESC-derived mesenchymal stem cell (MSC) line, HuES9.E1, for its ability to support the growth of undifferentiated hESC in feeder and feeder-free cultures. This line was previously reported to be karyotypically stable and phenotypically displayed MSC-like surface antigens and gene transcription profiles. In addition, like adult MSC, HuES9.E1 can be differentiated to adipocytes, osteocytes, and chondrocytes in vitro. When tested for its ability to support hESC growth, it was found that hESC maintained the undifferentiated morphology for >12 continuous passages in coculture with HuES9.E1 and >8 passages in feeder-free cultures supplemented with CM from HuES9.E1. Furthermore, the hESC cultures continued to express the pluripotent markers, Oct-4, SSEA-4, Tra-1-60, Tra-1-81, and retained a normal karyotype. When injected into severe combined immunodeficient (SCID) mice, hESC differentiated to form teratomas comprising of tissues representative of the three embryonic germ layers. Potentially, the ability to derive and use autogeneic feeders may provide a safe and accessible source of feeders for the expansion of hESC required in clinical applications.
人类胚胎干细胞(hESC)是多能细胞,在培养中可无限增殖,同时保留分化为体内任何细胞类型的能力。传统上,hESC要么直接培养在饲养层细胞上,要么培养在补充有饲养层细胞条件培养基(CM)的细胞外基质上。为了将异种动物感染的风险降至最低,已确定了几种原代人类饲养层细胞来源。然而,这并不能消除供体人类饲养层细胞的感染因子污染hESC的风险。在本研究中,我们评估了CD105 + /CD24 hESC来源的间充质干细胞(MSC)系HuES9.E1在饲养层和无饲养层培养中支持未分化hESC生长的能力。该细胞系先前报道其核型稳定,表型显示出类似MSC的表面抗原和基因转录谱。此外,与成人MSC一样,HuES9.E1在体外可分化为脂肪细胞、骨细胞和软骨细胞。在测试其支持hESC生长的能力时,发现hESC与HuES9.E1共培养时在>12个连续传代中保持未分化形态,在补充有HuES9.E1的CM的无饲养层培养中>8个传代保持未分化形态。此外,hESC培养物继续表达多能性标志物Oct-4、SSEA-4、Tra-1-60、Tra-1-81,并保留正常核型。当注射到严重联合免疫缺陷(SCID)小鼠中时,hESC分化形成包含三个胚胎胚层代表性组织的畸胎瘤。潜在地,获得和使用自体饲养层细胞的能力可能为临床应用中hESC的扩增提供一种安全且可获取的饲养层细胞来源。